The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

Karin Mausner-Fainberg1, Galia Luboshits, Adi Mor

  • 1The Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Atherosclerosis
|September 11, 2007
PubMed

Insights

Statins, widely used for lowering LDL cholesterol, may improve cardiovascular outcomes by boosting regulatory T cells (Tregs). Atorvastatin specifically increased functional Tregs in human blood, suggesting a novel immune mechanism for statin benefits.

Area of Science:

  • Immunology
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely prescribed for their lipid-lowering effects and cardiovascular benefits.
  • Immune-mediated mechanisms are increasingly recognized as crucial to the therapeutic actions of statins, particularly in atherosclerosis.
  • CD4(+)CD25(+) regulatory T cells (Tregs) are vital for immune homeostasis, suppressing excessive immune responses and preventing inflammatory diseases.

Purpose of the Study:

  • To investigate the hypothesis that statins modulate the number and functional capacity of circulating regulatory T cells (Tregs).
  • To explore potential immune-based mechanisms underlying the clinical benefits of statin therapy.

Main Methods:

  • Human peripheral blood mononuclear cells (PBMCs) and murine cells were treated in vitro and in vivo with various statins (atorvastatin, mevastatin, pravastatin, simvastatin).
  • Flow cytometry was used to quantify Tregs (CD4(+)CD25(+)Foxp3(+)) and assess Foxp3 expression levels.
  • Co-culture experiments were performed to determine the origin of statin-induced Tregs.

Main Results:

  • In vitro treatment of human PBMCs with atorvastatin significantly increased the number of CD4(+)CD25(high) and CD4(+)CD25(+)Foxp3(+) Tregs.
  • Atorvastatin-induced Tregs exhibited enhanced regulatory function, with Foxp3 expression levels correlating positively with regulatory potential.
  • Simvastatin and pravastatin increased Treg numbers in hyperlipidemic human subjects, while statin treatment showed no effect on Tregs in C57BL/6 mice.

Conclusions:

  • Statins, particularly atorvastatin, can significantly expand the peripheral pool of functional Tregs in humans.
  • This statin-induced modulation of Tregs may represent a key mechanism contributing to their plaque-stabilizing and anti-inflammatory effects.
  • The observed effects on Tregs appear to be species-specific, with no significant impact noted in mice.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...